| Ms Carolyn K Shiraki, MD | |
|
347 N Kuakini St, Honolulu, HI 96817-2306 | |
| (808) 847-5385 | |
| Not Available |
| Full Name | Ms Carolyn K Shiraki |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 38 Years |
| Location | 347 N Kuakini St, Honolulu, Hawaii |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275696452 | NPI | - | NPPES |
| 06302901 | Medicaid | HI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | MD8411 (Hawaii) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Queens Medical Center | Honolulu, HI | Hospital |
| Kuakini Medical Center | Honolulu, HI | Hospital |
| Pali Momi Medical Center | Aiea, HI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pacific Anesthesia Inc | 1951596329 | 75 |
News Archive
A pioneering lung cancer study, led by the University of Birmingham's Cancer Research UK Clinical Trials Unit, has highlighted important factors that will need to be considered in the next wave of precision medicine studies particularly in treating genomically complicated cancers.
"The Pancreatic Cancer Action Network applauds President Obama for his new Precision Medicine Initiative, and for making an important investment to advance cancer research and arm the scientific and medical community with the cutting edge tools and resources needed to fight cancer. This is especially welcome news for patients fighting pancreatic cancer who face a five-year survival rate of just seven percent.
In a national survey of U.S. medical practices, SK&A Information Services, Inc., a leading provider of healthcare information and research, found that office managers wield as much influence as lead physicians in determining the policy for allowing industry sales representatives to visit with physicians.
A recent presentation at an international cancer research conference in Greece reviewed the body of data on ProstaCaid, a dietary supplement compound for prostate health. A number of published studies demonstrate the formula's effects in supporting prostate health against specific prostate cancer cell lines and prostate urinary symptoms.
Combing data collected on thousands of California ovarian cancer patients, UC Davis researchers have determined that almost one-third survived at least 10 years after diagnosis.
› Verified 9 days ago
| Entity Name | Pacific Anesthesia Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538472451 PECOS PAC ID: 1951596329 Enrollment ID: O20101110001400 |
News Archive
A pioneering lung cancer study, led by the University of Birmingham's Cancer Research UK Clinical Trials Unit, has highlighted important factors that will need to be considered in the next wave of precision medicine studies particularly in treating genomically complicated cancers.
"The Pancreatic Cancer Action Network applauds President Obama for his new Precision Medicine Initiative, and for making an important investment to advance cancer research and arm the scientific and medical community with the cutting edge tools and resources needed to fight cancer. This is especially welcome news for patients fighting pancreatic cancer who face a five-year survival rate of just seven percent.
In a national survey of U.S. medical practices, SK&A Information Services, Inc., a leading provider of healthcare information and research, found that office managers wield as much influence as lead physicians in determining the policy for allowing industry sales representatives to visit with physicians.
A recent presentation at an international cancer research conference in Greece reviewed the body of data on ProstaCaid, a dietary supplement compound for prostate health. A number of published studies demonstrate the formula's effects in supporting prostate health against specific prostate cancer cell lines and prostate urinary symptoms.
Combing data collected on thousands of California ovarian cancer patients, UC Davis researchers have determined that almost one-third survived at least 10 years after diagnosis.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Carolyn K Shiraki, MD 4348 Waialae Ave, Honolulu, HI 96816-5767 Ph: (808) 847-5385 | Ms Carolyn K Shiraki, MD 347 N Kuakini St, Honolulu, HI 96817-2306 Ph: (808) 847-5385 |
News Archive
A pioneering lung cancer study, led by the University of Birmingham's Cancer Research UK Clinical Trials Unit, has highlighted important factors that will need to be considered in the next wave of precision medicine studies particularly in treating genomically complicated cancers.
"The Pancreatic Cancer Action Network applauds President Obama for his new Precision Medicine Initiative, and for making an important investment to advance cancer research and arm the scientific and medical community with the cutting edge tools and resources needed to fight cancer. This is especially welcome news for patients fighting pancreatic cancer who face a five-year survival rate of just seven percent.
In a national survey of U.S. medical practices, SK&A Information Services, Inc., a leading provider of healthcare information and research, found that office managers wield as much influence as lead physicians in determining the policy for allowing industry sales representatives to visit with physicians.
A recent presentation at an international cancer research conference in Greece reviewed the body of data on ProstaCaid, a dietary supplement compound for prostate health. A number of published studies demonstrate the formula's effects in supporting prostate health against specific prostate cancer cell lines and prostate urinary symptoms.
Combing data collected on thousands of California ovarian cancer patients, UC Davis researchers have determined that almost one-third survived at least 10 years after diagnosis.
› Verified 9 days ago
Dr. Hee Jung Park, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 321 N Kuakini St Ste 306, Honolulu, HI 96817 Phone: 808-792-9888 | |
Vien That Ton, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1575 S Beretania St #201-202, Honolulu, HI 96826 Phone: 808-946-1712 Fax: 808-946-1728 | |
Rony Newton Rathod, PA Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1401 S Beretania St Ste 400, Honolulu, HI 96814 Phone: 808-206-5301 | |
Sontaya L Fujikake, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1575 South Beretania Street, # 201 To 202, Honolulu, HI 96826 Phone: 808-946-1712 Fax: 808-946-1728 | |
Jun Zhuo Luo, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2914 Booth Rd Apt 12, Honolulu, HI 96813 Phone: 801-598-3679 | |
Lance M. Blaisdell, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 | |
Dr. Ligaya Stice, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1319 Punahou St, Honolulu, HI 96826 Phone: 808-536-0314 |